Sirnaomics Ltd. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Poon Hung Fai, was filed 25 Jun 2026.
Sirnaomics Ltd. - B: what insiders have been doing
Every trade that managers of Sirnaomics Ltd. - B disclose to HKEX is tracked on this page. The company sits in the Health Care sector. Between 31 October 2025 and 31 October 2026, 1 insider published 3 filings.
The flow runs one way only: 1 insider bought (3 purchases totalling €112k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Poon Hung Fai filed the largest purchase, €75k, on 10 December 2025. On the buying side, the filings list 1 senior executive among the declarants.
The clock since the last published purchase (25 June 2026) now reads 136 days. Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade.
For context, the typical company on the same exchange (median of 1,323 companies) published 4 filings over the same period, against 3 filings here. Looking back to 2022, when coverage begins, insiders filed 15 purchases and 37 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -10.2%Entry HK$4.60 · Close 30 Oct 2026 HK$4.13
- -60.1%Entry HK$7.84 · Close at T+365 HK$3.13
- -94.1%Entry HK$45.90 · Close at T+365 HK$2.69
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 20,300 shares@ HK$5.00160.025% mcap31.3% of flowShareXHKGHKEX:DA20260624E00381Canonical exit: 22 Sept 2026 (T+90)
- 38,000 shares@ HK$5.930.055% mcap68.7% of flowShareXHKGHKEX:DA20260401E00003Canonical exit: 28 Jun 2026 (T+90)
- 100,000 shares@ HK$6.831.1% of flowShareXHKGHKEX:DA20251210E00053Canonical exit: 8 Mar 2026 (T+90)
- 17,527,696 sharesShareXHKGHKEX:DA20250729E00433
- 17,527,696 sharesShareXHKGHKEX:DA20241206E00146
- 940,000 sharesShareXHKGHKEX:DA20241128E00292
- 42,783 sharesShareXHKGHKEX:DA20241128E00293
- 12,067 sharesShareXHKGHKEX:DA20241128E00291
- 17,527,696 shares@ HK$3.3698.9% of flowShareXHKGHKEX:DA20241025E00333
- 5,000 shares@ HK$7.1816.5% of flowShareXHKGHKEX:DA20240607E00081
- 5,000 shares@ HK$7.0016.1% of flowShareXHKGHKEX:DA20240606E00039
- 4,900 shares@ HK$7.586917.2% of flowShareXHKGHKEX:DA20240604E00492
- 5,000 shares@ HK$8.4019.4% of flowShareXHKGHKEX:DA20240527E00165
- 3,000 shares@ HK$8.3011.5% of flowShareXHKGHKEX:DA20240524E00488
- 5,000 shares@ HK$8.3019.2% of flowShareXHKGHKEX:DA20240524E00487
- 198,950 shares@ HK$8.303.5% of flowShareXHKGHKEX:DA20240524E00522Canonical exit: 20 Aug 2024 (T+90)
- 313,326 sharesShareXHKGHKEX:DA20240523E00459
- 1,163,600 shares@ HK$8.125116.7% of flowShareXHKGHKEX:DA20240325E00168
- 2,067,000 shares@ HK$9.686935.1% of flowShareXHKGHKEX:DA20240325E00167
- 250,000 shares@ HK$7.86683.5% of flowShareXHKGHKEX:DA20240325E00166
- 331,000 shares@ HK$8.19684.8% of flowShareXHKGHKEX:DA20240320E00262
- 1,660,150 shares@ HK$8.163123.9% of flowShareXHKGHKEX:DA20240320E00261
- 99,500 shares@ HK$10.14421.8% of flowShareXHKGHKEX:DA20240320E00260
- 1,560,000 shares@ HK$11.535633.1% of flowShareXHKGHKEX:DA20240307E00346
- 610,000 shares@ HK$13.288414.4% of flowShareXHKGHKEX:DA20240306E00269
25 of 79 declarations
About Sirnaomics Ltd. - B
Sirnaomics Ltd. - B is a company focused on developing RNA-based therapies for various diseases. It is listed on the Hong Kong Stock Exchange, XHKG.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
